Pasquale Viggiano | Medicine and Health Sciences | Best Researcher Award

Assist. Prof. Dr. Pasquale Viggiano | Medicine and Health Sciences | Best Researcher Award

Ricercatore University of Bari: Universita degli Studi di Bari Aldo Moro Italy

👨‍⚕️ Dr. Pasquale Viggiano, born on January 31, 1990, in Santa Maria Capua Vetere, Italy, is a distinguished ophthalmologist and researcher. With a robust academic background and practical expertise, he is currently a researcher in Ophthalmology at the Department of Biomedicine Translation and Neuroscience, University of Bari “Aldo Moro.”

Profile

Orcid

Education

🎓 Residency in Ophthalmology (2016-2020): University G. D’Annunzio Chieti-Pescara, Italy, guided by Prof. Leonardo Mastropasqua and Prof. Paolo Carpineto.
🎓 Medical Degree (2009-2015): Catholic University of Sacred Heart, Rome, Italy. Graduated on October 19, 2015.
🎓 Fellowship in Cataract Surgery (2023): Eye Research Center and Dr. Agarwal’s Eye Hospital, Chennai, India.

Experience

🔬 Current Position:

  • Since 2022: Researcher Ophthalmologist, University of Bari “Aldo Moro.”
    🩺 Past Roles:
  • 2021: Researcher at IRCCS-Fondazione Bietti, Rome.
  • 2014-2015: Internships in Ophthalmology and Anesthesiology at Catholic University of Sacred Heart, Rome.

Research Interests

🔍 Dr. Viggiano’s research focuses on:

  • Advanced optical coherence tomography (OCT).
  • Vascular changes in macular diseases.
  • Innovations in cataract and retinal surgery.

Awards

🏆 Nominee for excellence in clinical ophthalmology and scientific research.

Publications Top Notes:

📚 Highlighted Publications:

Borrelli E, Viggiano P et al., “In Vivo Mapping of the Choriocapillaris in Healthy Eyes.” Ophthalmology Retina, 2019. DOI.

Cited by: Numerous retinal imaging studies.

Borrelli E, Viggiano P, Mastropasqua R., “Vascular Changes in Age-Related Macular Degeneration.” Ann Eye Sci, 2019.

Cited by: Over 20 AMD-focused articles.

Boscia G, Viggiano P et al., “Choroidal Remodeling Following Different Anti-VEGF Therapies in Neovascular AMD.” Scientific Reports, 2024.

Cited by: Studies on anti-VEGF therapies.

ELENI MAGIRA | Health Professions | Best Researcher Award

Prof. Dr. ELENI MAGIRA | Health Professions | Best Researcher Award

HOSPITAL NATIONAL KAPODISTRIAN UNIVERISTY OF ATHENS Greece

Dr. Eleni Magira, MD, PhD, is a distinguished Professor in the 1st Department of Critical Care at Evangelismos Hospital, National and Kapodistrian University of Athens, Greece. With extensive experience in internal medicine and critical care, she is an accomplished researcher, educator, and medical practitioner dedicated to advancing immunogenetics and infectious disease care.

Profile

Google Scholar

🎓 Education

  • MD (1996): Aristotle University of Thessaloniki Medical School, Greece.
  • PhD (2008): University of Athens Medical School. Thesis: Immunogenetics aspects of Pulmonary Tuberculosis in the Greek Population.

💼 Experience

  • 1996-1997: General Physician, Primary Care Center, Greece.
  • 1998-2000: Post-Doctoral Fellow, Immunogenetics Lab, University of Pennsylvania, USA.
  • 2000-2005: Resident in Internal Medicine, Evangelismos General Hospital, Athens.
  • 2017-2018: Fulbright Visiting Scholar, MD Anderson Cancer Center, Texas, USA.
  • 2024-Present: Professor, Evangelismos Hospital, University of Athens.

🔬 Research Interests

  • Immunogenetics of infectious diseases, particularly pulmonary tuberculosis.
  • Fungal infections and their intersection with SARS-CoV-2.
  • Clinical epidemiology of invasive pulmonary aspergillosis in immunocompromised patients.

🏆 Awards

  • 2002: Travel Award, Federation of European Societies of Chemotherapy and Infection.
  • 2004: Travel Award, American Society of Histocompatibility and Immunogenetics.
  • 2002-2004: Recognition for contributions in immunogenetics and histocompatibility research.

📚 Publications Top Notes:

Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study

HLA-DRB1* 1101: a significant risk factor for sarcoidosis in blacks and whites

Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections: a European multicenter cohort study

Autoantibodies related to systemic autoimmune rheumatic diseases in severely ill patients with COVID-19

Anti–SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome: studies in 8 stuporous and comatose patients

Human leukocyte antigen Class II amino acid epitopes: susceptibility and progression markers for beryllium hypersensitivity

Relationship between ventilator-associated pneumonia and mortality in COVID-19 patients: a planned ancillary analysis of the coVAPid cohort

Differential distribution of HLA-DQβ/DRβ epitopes in the two forms of Guillain-Barré syndrome, acute motor axonal neuropathy and acute inflammatory demyelinating polyneuropathy …

Characteristics and risk factors for 28-day mortality of hospital acquired fungemias in ICUs: data from the EUROBACT study